The effects of SGLT2 inhibitors in patients with metabolic dysfunction-associated fatty liver disease; a narrative review

The effects of SGLT2 inhibitors in patients with metabolic dysfunction-associated fatty liver disease; a narrative review

Worldwide, metabolic dysfunction-associated fatty liver disease (MAFLD) is a significant public health concern, especially since more than fifty percent of people with type 2 diabetes are affected by it. This pathological condition includes all states of fatty liver disease, from non-alcoholic fatty...

Full description

Bibliographic Details
Main Authors: Mihaela Simona Popoviciu, Lorena Păduraru, Md Mominur Rahman, Fatema Akter Supti, Roxana Adriana Stoica, Delia Reurean-Pintilei, Cristina Ioana Bica, Simona Cavalu
Format: Article
Language:English
Published: Ion Motofei, Carol Davila University 2024-04-01
Series:Journal of Mind and Medical Sciences
Subjects:
nafld
sglt2 inhibitors
fatty liver
insulin resistance
metabolic syndrome
type 2 diabetes mellitus
inflammation
Online Access:https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1439&context=jmms

Internet

https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1439&context=jmms

Similar Items